Aclaris Therapeutics Inc (ACRS)
NASDAQ
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-01 | Dr. Jesse W. HallChief Medical Officer | -9.33k | 41.15k | Derivative Exercise and Sale | 4.41 | 27.05k | - |
| 2026-05-01 | Dr. Jesse W. HallChief Medical Officer | 27.05k | 0.00 | Derivative Exercise and Retained Stock | - | 27.05k | - |
| 2026-04-23 | BML Capital Management, LLC法人 | -300.00k | 1.36M | 売り | 4.53 | 13.95M | -2.11% |
| 2026-03-01 | Mr. Kevin BalthaserCFO | 1.70k | 0.00 | Derivative Exercise and Retained Stock | - | 187.45k | 0.91% |
| 2026-03-01 | Mr. Kevin BalthaserCFO | -677.00 | 1.94k | Derivative Exercise and Sale | 2.87 | 187.45k | - |
| 2026-02-03 | Mr. James LoeropChief Business Officer | 14.94k | 0.00 | Derivative Exercise and Retained Stock | - | 192.26k | 8.42% |
| 2026-02-03 | Mr. James LoeropChief Business Officer | -5.94k | 20.60k | Derivative Exercise and Sale | 3.47 | 192.26k | - |
| 2026-02-03 | Dr. Neal S. WalkerCo-Founder, CEO & Chairman | 44.86k | 0.00 | Derivative Exercise and Retained Stock | - | 1.54M | 2.99% |
| 2026-02-03 | Dr. Neal S. WalkerCo-Founder, CEO & Chairman | -18.61k | 64.58k | Derivative Exercise and Sale | 3.47 | 1.54M | - |
| 2026-02-03 | Dr. Hugh M. DavisPresident, COO & Director | 18.68k | 0.00 | Derivative Exercise and Retained Stock | - | 45.43k | 69.81% |
| 2026-02-03 | Mr. Kevin BalthaserCFO | 15.58k | 0.00 | Derivative Exercise and Retained Stock | - | 185.76k | 9.15% |
| 2026-02-03 | Mr. Kevin BalthaserCFO | -6.45k | 22.38k | Derivative Exercise and Sale | 3.47 | 185.76k | - |
| 2026-02-01 | Mr. James LoeropChief Business Officer | 22.81k | 0.00 | Derivative Exercise and Retained Stock | - | 177.32k | 14.77% |
| 2026-02-01 | Mr. James LoeropChief Business Officer | -10.69k | 37.51k | Derivative Exercise and Sale | 3.51 | 177.32k | - |
| 2026-02-01 | Mr. Kevin BalthaserCFO | 9.77k | 0.00 | Derivative Exercise and Retained Stock | - | 170.18k | 6.09% |
| 2026-02-01 | Mr. Kevin BalthaserCFO | -4.98k | 17.49k | Derivative Exercise and Sale | 3.51 | 170.18k | - |
| 2026-01-02 | Dr. Neal S. WalkerCo-Founder, CEO & Chairman | 19.20k | 0.00 | Derivative Exercise and Retained Stock | - | 1.50M | 1.30% |
| 2026-01-02 | Dr. Neal S. WalkerCo-Founder, CEO & Chairman | -9.95k | 28.66k | Derivative Exercise and Sale | 2.88 | 1.50M | - |
| 2025-12-31 | Mr. James LoeropChief Business Officer | 51.74k | 0.00 | Derivative Exercise and Retained Stock | - | 155.04k | 50.08% |
| 2025-12-31 | Mr. James LoeropChief Business Officer | -40.17k | 120.09k | Derivative Exercise and Sale | 2.88 - 3.01 | 155.04k | - |
| 2025-12-31 | Mr. Kevin BalthaserCFO | 67.81k | 0.00 | Derivative Exercise and Retained Stock | - | 160.41k | 73.22% |
| 2025-12-31 | Mr. Kevin BalthaserCFO | -26.65k | 79.62k | Derivative Exercise and Sale | 2.88 - 3.01 | 160.41k | - |
| 2025-12-02 | Dr. Hugh M. DavisPresident, COO & Director | 26.75k | 0.00 | Derivative Exercise and Retained Stock | - | 26.75k | - |
| 2025-06-06 | Dr. Andrew Newman SchiffIndependent Director | 4.79k | 0.00 | Derivative Exercise and Retained Stock | - | 13.96k | 52.29% |
| 2025-06-06 | Dr. Anand MehraIndependent Director | 4.79k | 0.00 | Derivative Exercise and Retained Stock | - | 714.82k | 0.68% |
| 2025-06-06 | Mr. Vincent J. MilanoIndependent Director | 4.79k | 0.00 | Derivative Exercise and Retained Stock | - | 17.32k | 38.27% |
| 2025-06-06 | Mr. William D. HumphriesIndependent Director | 4.79k | 0.00 | Derivative Exercise and Retained Stock | - | 33.53k | 16.68% |
| 2025-06-06 | Mr. Christopher P. MolineauxLead Independent Director | 4.79k | 0.00 | Derivative Exercise and Retained Stock | - | 57.96k | 9.02% |
| 2025-06-06 | Dr. Maxine GowenIndependent Director | 4.79k | 0.00 | Derivative Exercise and Retained Stock | - | 21.75k | 28.26% |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。